Quadrant Capital Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.36M | Hold |
2,605
| – | – | 0.04% | 429 |
|
|
2025
Q4 | $1.52M | Hold |
2,605
| – | – | 0.05% | 354 |
|
|
2025
Q3 | $1.19M | Hold |
2,605
| – | – | 0.04% | 424 |
|
|
2025
Q2 | $788K | Sell |
2,605
-16
| -0.6% | -$4.77K | 0.03% | 605 |
|
|
2025
Q1 | $868K | Buy |
2,621
+2,599
| +11,814% | +$854K | 0.03% | 436 |
|
|
2024
Q4 | $6.79K | Hold |
22
| – | – | ﹤0.01% | 2236 |
|
|
2024
Q3 | $4.67K | Hold |
22
| – | – | ﹤0.01% | 2332 |
|
|
2024
Q2 | $6.16K | Sell |
22
-20
| -48% | -$4.76K | ﹤0.01% | 2246 |
|
|
2024
Q1 | $11.2K | Buy |
42
+20
| +91% | +$4.71K | ﹤0.01% | 2059 |
|
|
2023
Q4 | $5.09K | Buy |
22
+9
| +69% | +$1.57K | ﹤0.01% | 2273 |
|
|
2023
Q3 | $1.9K | Sell |
13
-1
| -7% | -$188 | ﹤0.01% | 2406 |
|
|
2023
Q2 | $3.23K | Buy |
14
+1
| +8% | +$271 | ﹤0.01% | 2306 |
|
|
2023
Q1 | $3.15K | Sell |
13
-30
| -70% | -$8.17K | ﹤0.01% | 2332 |
|
|
2022
Q4 | $12.5K | Buy |
+43
| New | +$4.21K | ﹤0.01% | 1847 |
|
|
2022
Q3 | – | Sell |
-3
| Closed | – | – | 2738 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 2656 |
|
|
2022
Q1 | $0 | Buy |
3
+2
| +200% | +$169 | ﹤0.01% | 2613 |
|
|
2021
Q4 | $0 | Sell |
1
-15
| -94% | -$1.23K | ﹤0.01% | 2626 |
|
|
2021
Q3 | $1K | Buy |
16
+14
| +700% | +$1.21K | ﹤0.01% | 2343 |
|
|
2021
Q2 | $0 | Sell |
2
-1
| -33% | -$118 | ﹤0.01% | 2491 |
|
|
2021
Q1 | $0 | Buy |
+3
| New | +$350 | ﹤0.01% | 2425 |
|
|
2020
Q2 | – | Sell |
-3
| Closed | – | – | 2327 |
|
|
2020
Q1 | $0 | Buy |
+3
| New | +$250 | ﹤0.01% | 2199 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
